News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Facet Biotech Chief Business Officer “Terminated”
January 7, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
January 6, 2009 - San Francisco Business Times - Redwood City’s Facet Biotech Corp. — recently spun off from PDL BioPharma Inc. — will part with its chief business officer Friday.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Venture capital
LifeMine raises $263M in mission to improve organ transplant aftercare
August 6, 2026
·
2 min read
·
Annalee Armstrong
Earnings
Lilly confident in slow and steady Foundayo launch, as ex-US sales shine
August 5, 2026
·
3 min read
·
Annalee Armstrong
Regulatory
Lilly, FDA retatrutide biologic dispute comes to a head as submission nears
August 5, 2026
·
3 min read
·
Annalee Armstrong
M&A
No deal between AstraZeneca and BMS, senior source insists:
Reuters
August 5, 2026
·
1 min read
·
Gabrielle Masson